Celixir cleared to start trial of stem cell therapy for heart failure – PMLiVE
PMLiVECelixir cleared to start trial of stem cell therapy for heart failurePMLiVEUK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel – its stem cell-based therapy for heart failure – that could potentially support app… Continue reading
